Market news

Ingevity (NYSE:NGVT) is nearing completion of a strategic portfolio transformation that has narrowed its focus to its Performance Materials and Pavement Technologies businesses, President and Chief Executive Officer David Li said during a Water Tower Research conference session. Li, who became CEO

Ingevity has delivered a solid multi year run in its share price, which naturally raises a question for anyone looking at the stock today. Is the current market value of Ingevity really in line with what its earnings can support, or has the price moved ahead of the underlying profit engine? Over the past 3 years, Ingevity has returned 51.6%, putting real weight on the question of whether that gain lines up with the business's earnings power. The company’s ability to convert its specialty...

Here is how Ingevity (NGVT) and Solstice Advanced Materials (SOLS) have performed compared to their sector so far this year.

NGVT's 19.2% YTD rally is backed by portfolio optimization, stronger hybrid demand, pricing gains and higher margins, fueling earnings growth.

NORTH CHARLESTON, S.C., September 03, 2026--Ingevity will participate in a fireside chat during the 2026 Jefferies Industrials Conference.

Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NGVT's raised 2026 outlook, portfolio transformation and new growth platforms support its momentum and higher-return investment focus.

NORTH CHARLESTON, S.C., August 18, 2026--Ingevity included in TIME America’s Best Companies 2026 list

Detailed price information for Ingevity Corp (NGVT-N) from The Globe and Mail including charting and trades.

Detailed price information for Ingevity Corp (NGVT-N) from The Globe and Mail including charting and trades.

Detailed price information for Ingevity Corp (NGVT-N) from The Globe and Mail including charting and trades.

NORTH CHARLESTON, S.C., August 05, 2026--Ingevity Corporation has published its 2025 Sustainability Report titled "A Decade of Performance, a Future of Possibility."

Why Ingevity’s latest earnings and buyback matter for shareholders Ingevity (NGVT) just posted second quarter 2026 results that show higher profitability compared with last year’s loss, alongside lower sales and the completion of a multi year share repurchase program. See our latest analysis for Ingevity. At a share price of $73.11, Ingevity has gained 21.67% on a year-to-date share price basis, while the 1-year total shareholder return of 80.97% points to strong recent momentum despite some...

Ingevity Corporation recently reported past second-quarter 2026 results, with sales of US$314.1 million and net income of US$35.3 million, marking a return to profitability versus a loss a year earlier. Alongside this earnings rebound, Ingevity completed a sizeable share repurchase program totaling 4,381,177 shares for US$289.45 million, retiring about 12.01% of its outstanding stock since 2022. We’ll now examine how this move from loss to profit could influence Ingevity’s investment...

Ingevity (NYSE:NGVT) reported second-quarter 2026 results marked by higher adjusted earnings, margin expansion and progress on its portfolio simplification efforts, as the company raised its full-year adjusted EBITDA and earnings-per-share outlook. Chief Executive Officer and President Dave Li said

Moby summary of Ingevity Corporation's Q2 2026 earnings call

Adjusted EBITDA surged nearly 14% with margins expanding to 36.6%, driven by exceptional Performance Materials results and a key PFAS filtration contract win.

Ingevity (NGVT) delivered earnings and revenue surprises of +32.82% and +4.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

NORTH CHARLESTON, S.C., July 29, 2026--Ingevity raises full year Adjusted EBITDA outlook following a solid start to the year

NORTH CHARLESTON, S.C., July 16, 2026--Ingevity announced Evotherm® P35 warm-mix additive has received approval from Germany’s Federal Highway Research Institute, known as BASt.

Detailed price information for Ingevity Corp (NGVT-N) from The Globe and Mail including charting and trades.

NGVT shares are up 24.8% YTD, beating the industry, as portfolio optimization, hybrid demand and pricing actions drive earnings and boost outlook.